13F Portfolios

Tetragon Partners GP Ltd 13F: Portfolio & Holdings

This page tracks the 13F filings for Tetragon Partners GP Ltd (SEC CIK 0001515070), a GRAND CAYMAN-based hedge fund managing $0.50 billion across 34 reported positions as of Q1 2026, per its quarterly SEC Form 13F-HR filing. The Q1 2026 13F filing shows 63.4% of Tetragon Financial Group's reported portfolio concentrated in Technology. Reported 13F market value decreased quarter-over-quarter.

By portfolio weight, the top holdings are UIPATH INC (PATH) at 54.98%, KOLIBRI GLOBAL ENERGY INC (KGEI) at 7.37%, and WARNER BROS DISCOVERY INC (WBD) at 4.98%. Ranked by the share of each peer fund's 13F equity portfolio that overlaps with Tetragon Financial Group's disclosed positions as of Q1 2026, the closest peers are Commodore Capital 13F (35.1%), Exome Asset Management 13F (22.3%), and Deep Track 13F (20.6% overlap).

Most recently, the manager opened a new position in WARNER BROS DISCOVERY INC (WBD) (4.98%), fully exited RAPT THERAPEUTICS INC (SYN_75382E208) , added to SILENCE THERAPEUTICS PLC (SLN) (+72.47% shares), and trimmed ANNEXON INC (ANNX) (-36.41% shares). View the full Q1 2026 allocation shift and trading report →

13F AUM
$0.5B
Equity Positions
34
Top-10 Concentration
83.0%
Largest Sector · 63.4%
Technology
Longest-Held Position · 32 qtrs
AUTL
Median Holding Period
3 Qtrs

Top 10 Holdings — Tetragon Financial Group — Q1 2026

Largest 13F positions disclosed by Tetragon Financial Group, ranked by portfolio weight. Full multi-quarter history and the broader institutional holder base for each ticker linked per row.

Top 10 disclosed equity positions for Tetragon Financial Group in Q1 2026 — ranked by portfolio weight; share count and market value sourced from SEC Form 13F-HR filings.
# Issuer Ticker Sector Weight Position Value Detail
1 UIPATH INC PATH Technology 54.98% $279.8M Position History All Holders
2 KOLIBRI GLOBAL ENERGY INC KGEI Energy 7.37% $37.5M Position History All Holders
3 WARNER BROS DISCOVERY INC NEW WBD Communication Services 4.98% $25.4M Position History All Holders
4 WORKIVA INC WK Technology 2.93% $14.9M Position History All Holders
5 LYFT INC LYFT Technology 2.61% $13.3M Position History All Holders
6 SPRINKLR INC CXM Technology 2.59% $13.2M Position History All Holders
7 AUTOLUS THERAPEUTICS LTD AUTL Healthcare 2.58% $13.1M Position History All Holders
8 CELLDEX THERAPEUTICS INC CLDX Healthcare 1.95% $9.9M Position History All Holders
9 ARROWHEAD PHARMACEUTICALS INC ARWR Healthcare 1.57% $8.0M Position History All Holders
10 NEKTAR THERAPEUTICS NKTR Healthcare 1.46% $7.4M Position History All Holders

View Tetragon Financial Group's Q1 2026 allocation shift and trading report →

Latest

Portfolio composition

Sectors, concentrations, and a tap-through treemap of every position in the fund's latest 13F.

Allocation by stock34 positions · click any tile for institutional holders
Allocation by sector5 sectors · same palette as the stock tiles

Quarterly shiftsQ1 2026 vs previous quarter

Top movers in Tetragon Financial Group's Form 13F versus the prior reporting quarter. Δ Weight is the change in portfolio weight (percentage points); Δ Shares is the percent change in share count.

Top buys
CompanyTickerΔ WeightΔ Shares
SILENCE THERAPEUTICS PLCSLN+0.18%+72.47%
WORKIVA INCWK+0.20%+66.67%
KRYSTAL BIOTECHKRYS+0.38%+66.48%
NEKTAR THERAPEUTICSNKTR+0.84%+48.71%
UIPATH INCPATH+-5.32%+44.46%
Top sells
CompanyTickerΔ WeightΔ Shares
ANNEXON INCANNX-0.74%-36.41%
MAPLIGHT THERAPEUTICS INCMPLT-0.16%-31.86%
PRAXIS PRECISION MEDICINES IPRAX-0.42%-30.50%
AXSOME THERAPEUTICSAXSM-0.37%-25.53%
KOLIBRI GLOBAL ENERGY INCKGEI1.63%-1.44%

Waterfall analysis

Top movers versus the prior reporting quarter. Left panel bridges market-value change in USD millions; right panel shows share-count change in %.

Δ Market value+$34.6M · +7.31% QoQ
Δ Shares heldNet +21.18% vs. prior quarter

Holding period analytics

Distribution of holding periods for all 598 stocks the fund has ever held (up to selected quarter):

Which Funds Hold a Similar Portfolio to Tetragon Financial Group?

Ranked by percentage of the peer fund's 13F equity portfolio that overlaps with Tetragon Financial Group's positions in Q1 2026.

Funds with the most portfolio overlap with Tetragon Financial Group in Q1 2026 — Ranked by overlap percentage
# Fund Shared Positions Overlap %
1 Commodore Capital 13F 8 35.1%
2 Exome Asset Management 13F 7 22.3%
3 Deep Track 13F 9 20.6%
4 Avoro Capital Advisors 13F 5 16.1%
5 Baker Bros. Advisors 13F 12 13.6%

How Has Tetragon Financial Group's AUM Changed Over Time?

Quarterly 13F-reported AUM for Tetragon Financial Group, derived from aggregate reported position market values disclosed to the U.S. SEC.

Methodology & FAQ

How We Track Tetragon Financial Group Holdings

Our data is systematically aggregated directly from quarterly Form 13F-HR disclosures submitted to the U.S. Securities and Exchange Commission (SEC).

  • Who Must File (Reporting Threshold): This dataset includes filings from U.S. institutional investment managers, hedge funds, mutual funds, university endowments, and family offices managing at least $100 million in Section 13(f) securities (including equities, options, convertibles, ETFs, and warrants).
  • What is Included (Data Scope): By regulation, 13F filings include long positions in U.S. exchange-listed stocks, ETFs, shares of closed-end investment companies, and convertible debt, as defined in the SEC's official Section 13(f) securities list . For listed options (calls/puts) the reported value is based on the notional value.
  • Portfolio Weight Explained (Metric Definition): “Portfolio Weight” shows how much of a fund's total reported 13F portfolio value (excluding listed options) is allocated to a specific position on the reporting date.
  • How to Use This Data (Interpretation): Quarter-over-quarter changes in shares and portfolio weight reflect a combination of active trading and market price movements. These are descriptive metrics of fund allocation, not explicit buy or sell signals.
What does Tetragon Financial Group's 13F filing disclose about their portfolio?

A Form 13F-HR filed by Tetragon Financial Group with the U.S. SEC discloses all long positions in Section 13(f) securities — U.S.-listed equities, ETFs, closed-end funds, and listed put/call options — held at quarter-end with a market value of at least $200,000 or 10,000 or more shares. Pactolio aggregates these filings to surface Tetragon Financial Group’s reported portfolio weights, share counts, and quarter-over-quarter allocation shifts in a structured format. The filing represents a point-in-time snapshot of disclosed long-side exposure, not a real-time or complete view of the fund’s total book.

How do you measure conviction in Tetragon Financial Group's portfolio allocations?

Conviction is measured by portfolio weight — the percentage of Tetragon Financial Group’s total reported 13F market value allocated to a given position — rather than by absolute share count or dollar value alone. A position representing a disproportionately large share of the fund’s disclosed book signals high-conviction allocation, regardless of whether it ranks among the fund’s largest absolute holdings. Tracking how that weight changes quarter-over-quarter separates active reallocation decisions from passive price appreciation drift.

What is excluded from Tetragon Financial Group's 13F — short positions, swaps, and derivatives?

SEC Form 13F requires disclosure of long positions only. Specifically excluded are: short interest, total return swaps, credit default swaps, and all OTC derivatives — none of which appear in 13F filings regardless of position size. Listed put and call options must be disclosed but are excluded from portfolio weight calculations on this platform so that reported weights reflect direct equity exposure and remain comparable across filers. This means Tetragon Financial Group’s 13F represents the reported long book, which may differ materially from its net economic exposure.

When is Tetragon Financial Group's 13F data available, and how large is the reporting lag?

Investment managers must submit Form 13F within 45 calendar days of each quarter-end (the T+45 deadline). Pactolio ingests filings directly from SEC EDGAR as they are published — managers who file early appear in our system before the deadline, while late filers are captured on their actual filing date. The quarter label shown at the top of this page reflects the most recently processed 13F cycle for Tetragon Financial Group. The inherent reporting lag means the data always reflects positions as of the prior quarter-end, not current holdings.

Who must file a Form 13F with the SEC, and does Tetragon Financial Group qualify?

Under SEC Rule 13f-1, any investment manager — including hedge funds, family offices, registered investment advisers, pension funds, and university endowments — that exercises investment discretion over $100 million or more in Section 13(f) securities at any point during a calendar year must file Form 13F for that year. Tetragon Financial Group meets this threshold, which is why its holdings are publicly disclosed and accessible on this platform. The $100 million threshold is evaluated on a rolling basis, meaning new filers can enter and existing filers can exit the disclosure regime as AUM crosses that boundary.